MIRA INFORM REPORT

 

 

Report No. :

349429

Report Date :

07.11.2015

 

IDENTIFICATION DETAILS

 

Name :

NAM BUK SURGICAL

 

 

Registered Office :

55, Digital-ro 33-gil, Guro-gu, Seoul, Korea, 08376, Rm. 304, E&C Venture Dream Tower 2-cha

 

 

Country :

South Korea

 

 

Date of Incorporation :

03.01.2002

 

 

Com. Reg. No.:

119-06-82292

 

 

Legal Form :

Sole Proprietorship

 

 

Line of Business :

Wholesales of Medical Supplies and Devices.

 

 

No. of Employees :

10

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Status :

Moderate

Payment Behaviour :

Unknown

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

South Korea

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

SOUTH KOREA - ECONOMIC OVERVIEW

 

South Korea over the past four decades has demonstrated incredible economic growth and global integration to become a high-tech industrialized economy. In the 1960s, GDP per capita was comparable with levels in the poorer countries of Africa and Asia. In 2004, South Korea joined the trillion-dollar club of world economies. A system of close government and business ties, including directed credit and import restrictions, initially made this success possible. The government promoted the import of raw materials and technology at the expense of consumer goods, and encouraged savings and investment over consumption. The Asian financial crisis of 1997-98 exposed longstanding weaknesses in South Korea's development model, including high debt/equity ratios and massive short-term foreign borrowing. GDP plunged by 7% in 1998, and then recovered by 9% in 1999-2000. South Korea adopted numerous economic reforms following the crisis, including greater openness to foreign investment and imports. Growth moderated to about 4% annually between 2003 and 2007. South Korea's export focused economy was hit hard by the 2008 global economic downturn, but quickly rebounded in subsequent years, reaching over 6% growth in 2010. The US-Korea Free Trade Agreement was ratified by both governments in 2011 and went into effect in March 2012. Between 2012 and 2014, the economy experienced slow growth due to sluggish domestic consumption and investment. The administration in 2015 is likely to face the challenge of balancing heavy reliance on exports with developing domestic-oriented sectors, such as services. The South Korean economy's long-term challenges include a rapidly aging population, inflexible labor market, dominance of large conglomerates (chaebols), and the heavy reliance on exports, which comprise about half of GDP. In an effort to address the long term challenges and sustain economic growth, the current government has prioritized structural reforms, deregulation, promotion of entrepreneurship and creative industries, and the competitiveness of small and medium enterprises.

 

Source : CIA


Basic Information

 

Company Name

NAM BUK SURGICAL

(Korean Company Name : “남북써지칼”)

Registered Address

55, Digital-ro 33-gil, Guro-gu, Seoul, Korea

Building

Rm. 304, E&C Venture Dream Tower 2-cha

Zip Code

08376

Tel

+82-2-6330-1800

Fax

+82-2-6330-1804

E-mail

nambuk8@nbsurgical.co.kr

Website

www.nambuksurgical.com

Trading Address

Rm. 304, E&C Venture Dream Tower 2-cha, 55, Digital-ro 33-gil, Guro-gu, Seoul, Korea

(Old Address System : Rm. 304, E&C Venture Dream Tower 2-cha, 197-10, Guro 3-dong, Guro-gu, Seoul, Korea)

Tel

+82-2-6330-1800

Fax

+82-2-6330-1804

Other Address

 

Tel

 

Fax

 

Type

Import

Industry

Wholesales of Medical Supplies and Devices

  Main Business

Skin Marker, Compression Stocking, Surgical Instruments, Needle Holders, Scissors, Clamp, Forceps, Aorta/Vein Punches, Perometer

  Sub Business

 

Established (mm/dd/yyyy)

01/03/2002

 

 

Detailed Products

 

Activity

Detailed Products (UNSPSC)

Sell

Stockings(53102401)

Sell

Body shaping garments(53102307)

Sell

Medical equipment and accessories and supplies(42000000)

 

 

CEO’s

 

Name

Park Ki-Soo

Address

 

Date of Birth

07/07/1964

Title

Owner

Sex

Male

Nationality

Korean

 

Profiles

 

Capital (KRW)

Not Applicable to the Sole Proprietorship

Employees

10

Formation

Sole Proprietorship

Bank Details

N/A

Corporate Registered No.

Not Applicable to the Sole Proprietorship

Business Registered No.

119-06-82292

Permit & Licenses

Int’l Trade No.: 45406539

Shareholder Position

The owner has 100% shares.

Company History

01/03/2002 Established as the present name

 

 

Detailed Information

 

Management

 

Job Description

Title

Name

Sex

Nationality

Inauguration Date

Owner

Mr.

Park Ki-Soo

Male

Korean

01/03/2002

 

 

Financials

 

The financials are not available, and the Subject Company does not have any obligations to release its financials to the public.

 

 

Financial Description

 

Authorized Capital(KRW)

Not Applicable to the Sole Proprietorship

Paid-Up Capital(KRW)

Not Applicable to the Sole Proprietorship

Total Issued Shares

Not Applicable to the Sole Proprietorship

 

 

Products, Technologies, Services Description

 

Main Products & Services

Skin Marker, Compression Stocking, Surgical Instruments, Needle Holders, Scissors, Clamp, Forceps, Aorta/Vein Punches, Perometer

Detailed Products Spec.

 

Technologies Acquired

 

 

Trade Partners & Competitors

 

Suppliers

MEDI(GERMANY)

SCANLAN WORLD WIDE(USA)

BARD(USA)

LOHMAN & RAUSCHER(AUSTRIA)

MEGO AFEK(ISRAEL)

Customers

 

Competitors

DOGO MEDICAL CORP.

RM. 603, ACE TECHNO TOWER, 468, GANGSEO-RO, GANGSEO-GU, SEOUL, KOREA

TEL:+82-2-3664-1188  FAX:+82-2-3664-1187

 

ROTHEM MEDIC CO.

2ND FL., DONGSHIN BLDG., 947-1, BONGCHEON 1-DONG ,GWANAK-GU, SEOUL, KOREA

TEL:+82-2-873-4276  FAX:+82-2-873-4290

 

LEG KOREA CO., LTD.

RM.501, DAERYUK BLDG., 47, GONGHANG-DAERO 55-GIL, GANGSEO-GU, SEOUL, KOREA

TEL:+82-2-3662-0103

 

 

Sales by Region (Activity & Markets)

 

The Subject imports from USA, Germany, Austria and Israel.

 

 

Court Action

 

Not Available.

 

 

News Clipping

 

------

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.79

UK Pound

1

Rs.99.95

Euro

1

Rs.71.55

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAS

 

 

Report Prepared by :

TPT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.